CA
NZ
UK
AU
IND
US
Director Olivier Roger Jarry filed a Form 4 with the SEC on October 30, 2026, disclosing the grant of stock options to purchase 300,000 shares of OS Therapies Inc common stock on October 22, 2026.
Belite Bio, Inc. Chief Executive Officer and Director Lin Yu-Hsin filed a statement of changes in beneficial ownership on October 30, 2026, reporting the vesting of 5,000 ordinary shares under a restricted stock unit award originally granted on September 15, 2025.
Hao-Yuan Chuang, Chief Financial Officer and Director of Belite Bio, Inc, filed a Form 4 on October 30, 2026, disclosing the vesting of 5,000 ordinary shares from a restricted stock unit award originally granted on September 15, 2025.
Director Theodore F. Search filed a Form 4 with the SEC on October 30, 2026, disclosing a stock option grant and reporting his current beneficial ownership of common stock in OS Therapies Inc (NYSE:OSTX).
OS Therapies Inc director John Ciccio filed a Form 4 on October 30, 2026, disclosing the grant of 300,000 stock options and reporting his current beneficial ownership of common stock.
OS Therapies Inc President and CEO Paul A. Romness filed a Form 4 on October 30, 2026, reporting the grant of 900,000 stock options on October 22, 2026, with an exercise price of $1.25 per share.
Robert Petit, Chief Medical Officer and Chief Scientific Officer of OS Therapies Inc, filed a Form 4 on October 30, 2026, disclosing the grant of stock options to purchase 200,000 shares of common stock on October 22, 2026.
Director Nicholas Reyland Liuzza Jr. filed a Form 4 with the SEC on October 30, 2026, reporting the acquisition of two tranches of restricted stock units in Red Cat Holdings, Inc. (NASDAQ:RCAT) with a transaction date of October 28, 2026.
Director Paul Funk II of Red Cat Holdings, Inc. filed a Form 4 on October 30, 2026, reporting the acquisition of two tranches of restricted stock units in Red Cat Holdings common stock, with transaction dates of October 28, 2026.
Director Joseph David Freedman filed a Form 4 with the SEC on October 30, 2026, disclosing the acquisition of two tranches of restricted stock units in Red Cat Holdings, Inc. (NASDAQ:RCAT) on October 28, 2026.
Please wait processing your request...